جست‌وجوی استاد و پژوهشگر

• Public Health
• Global Health
• Epidemiology
• +۵ مورد دیگر

Professor James Lewis is a faculty member in the School of Social Sciences at Cardiff University and a co-investigator at the DECIPHer Centre. He leads international research initiatives, including the £2.9m HCRW Sustainability Funding (2025-30) and the £5m ESRC-funded Local Policy and Innovation Partnership for Rural Wales. Previously, he directed the Cardiff University Y Lab (2018-2023), which attracted £12m in funding and won a Cardiff University Excellence Award for Innovation (2022). His research focuses on public health challenges, including tuberculosis and HIV control, health system innovation, and global health interventions. Education: PhD in Epidemiology (Imperial College London, 2005) MSc in Applied Statistics (University of Oxford, 2000) BA in Mathematics (University of Cambridge, 1999) Research Interests: Professor Lewis specializes in pragmatic evaluations of health system innovations, particularly in TB and HIV. His work emphasizes intervention design, implementation science, and the integration of digital tools in healthcare. He has led studies in sub-Saharan Africa, South Asia, and South America, addressing issues like medication adherence, TB preventive therapy, and social determinants of health. Recent projects include evaluating mobile health (mHealth) adherence support for HIV patients in the Philippines and assessing household TB contact tracing in South Africa. Awards & Grants: £29m in total grant funding, including £6.5m as principal investigator 2022 Cardiff University Excellence in Innovation Award Advising & Teams: Supervised PhD students: Nicole Gelfert, Kavi Velen, Cara O'Connor Leads DECIPHer’s Executive Management team Collaborates with global partners (e.g., LSHTM, World Bank) Labs/Teams: DECIPHer Centre: Focuses on complex public health interventions Y Lab: Specializes in public services innovation

Helena Feaseyمشاهده پروفایل

پژوهشگر

• Public Health
• Epidemiology
• Behavioral Science
• +۵ مورد دیگر

Dr Helena Feasey is a Public Health Researcher and Arclight Development Manager at the School of Medicine, University of St Andrews. Her work focuses on epidemiology and behavioral change interventions to improve global health outcomes, particularly in tuberculosis (TB) diagnosis and low-cost medical technology implementation. She leads the Arclight project distributing ophthalmoscopes/otoscopes to enhance eye and ear health in low-resource settings. Previously, she conducted extensive research on TB diagnosis and public health strategies in Malawi, contributing to community-based interventions and genomic studies. Her research addresses TB-HIV co-infection dynamics, spatial epidemiology of TB transmission, and the impact of pandemics like COVID-19 on disease notification systems. She has led cluster-randomized trials (e.g., SCALE trial) and systematic reviews evaluating active TB case-finding strategies. Key contributions include identifying TB underdiagnosis hotspots and analyzing TB mortality determinants in urban populations. Feasey’s work aligns with UN Sustainable Development Goals (SDGs), particularly SDG 3 (Good Health and Well-Being). Her datasets and software tools, including genomic and spatial analysis frameworks, are publicly available via GitHub and OSF platforms. She collaborates with global health organizations to translate research findings into actionable public health policies.

Lorenzo Casaburiمشاهده پروفایل

دانشیار

• Development Economics
• Political Economy
• Behavioral Economics
• +۴ مورد دیگر

Lorenzo Casaburi is the UBS Foundation Associate Professor of Development Economics (with tenure) at the University of Zurich's Department of Economics. His research focuses on economic development in Sub-Saharan Africa, particularly agricultural finance, competition, and land markets. He holds affiliations with BREAD, CEPR, IGC, IPA, and J-PAL, and serves as an Associate Editor for Econometrica and the Economic Journal . Casaburi earned his Ph.D. in Economics from Harvard University and completed a postdoctoral fellowship at Stanford SIEPR. Education: Ph.D. in Economics, Harvard University (2013) B.A. in Economics (cum laude), University of Bologna (2004) Education Abroad Program, University of California, Berkeley (2003-2004) Research Interests: Development Economics, Political Economy, Behavioral Economics, Public Finance. His work emphasizes agricultural markets, land policies, and institutional dynamics in Sub-Saharan Africa, supported by grants from the ERC, Swiss National Science Foundation, and USAID. Awards: Prize for Excellence in Development (2019) Excellence in Refereeing Award (AER, 2017, 2018, 2020) Harvard Teaching Excellence (2010) Grants & Supervision: Secured over $3.8M in research funding. Advised six Ph.D. students placed in top institutions like NYU Abu Dhabi, LSE, and Brown University. Leads projects on land rentals, cash transfers, and ICT in agriculture. Labs/Teams: Collaborates with IPA, J-PAL, and the International Growth Centre on field experiments and policy evaluations in Africa and beyond.

Hailay Gesesewمشاهده پروفایل

دانشیار

• HIV Care Continuum
• Conflict and Health
• Perilous Medicine in Africa
• +۳ مورد دیگر

Hailay Gesesew is an Associate Professor of Epidemiology and Honorary Researcher at Lancaster University's Faculty of Health and Medicine. He holds a Principal Research Fellow position with Australia's National Health and Medical Research Council (NHMRC). His work focuses on HIV care continuum in low- and middle-income countries, conflict-affected health systems, and social determinants of health. He collaborates with Ethiopian research institutes and universities. Current research includes NHMRC-funded projects on HIV peer counselors in Ethiopia (2020-2024) and a cluster randomized trial evaluating the 'Teach-Test-Link-Trace' model. Other projects address CALD youth wellbeing in South Australia and vicarious trauma among Tigrayan Australians. As a mixed-methods researcher, Gesesew co-supervises 9 PhD students exploring conflict, HIV care, universal health coverage, and youth mental wellbeing. He leads grants totaling over AUD 5M from NHMRC, The Hospital Research Foundation, and Primary Health Network Adelaide.

• Palliative Care
• End of Life Care
• Community-Based Care
• +۷ مورد دیگر

Professor Catherine Walshe is a Professor of Palliative Care and Co-Director of the International Observatory on End of Life Care at Lancaster University's Division of Health Research. She holds a leadership role as Editor-in-Chief of the journal *Palliative Medicine*, a premier interdisciplinary publication in the field. Her research focuses on improving palliative care delivery in primary/community settings, symptom management at end of life, and advancing research methods in end-of-life care. Current projects include Horizon Europe-funded initiatives addressing COPD and dementia care, as well as NIHR-funded programs such as the Palliative and End of Life Care Policy Research Unit. Her teaching includes leading the internationally recognized PhD in Palliative Care program, where she serves as Admissions Tutor. She actively supervises PhD students in areas like palliative care provision in care homes and volunteer roles. Key collaborations span pan-European consortia, including projects with Vrije Universiteit Brussel (VUB) and University College Cork. Research interests emphasize building evidence-based practices, particularly for vulnerable populations such as those with advanced dementia or cancer. Notable contributions include the mySUPPORT care booklet initiative for nursing homes and CovPall, analyzing pandemic responses in palliative care. She also explores digital health interventions and telehealth solutions for emotional support in palliative care settings. Professional recognition includes her fellowship with the Queens Institute of Community Nursing. Her work bridges clinical practice and academia, with a focus on translating research into policy and clinical practice improvements. Ongoing projects aim to strengthen palliative care networks and address gaps in service provision across healthcare systems.

Sandra Eldridgeمشاهده پروفایل

استاد

• Biostatistics
• Cluster Randomized Trials
• Pilot and Feasibility Studies
• +۳ مورد دیگر

Professor Sandra Eldridge is an Honorary Professor of Biostatistics at Queen Mary University of London, affiliated with Barts and The London School of Medicine and Dentistry. She directs the UKCRC Registered Pragmatic Clinical Trials Unit and serves as Associate Dean for Strategic Developments and Equality, Diversity, and Inclusion lead. Her expertise spans cluster randomized trials, pilot/feasibility studies, and pragmatic trials, with a focus on methodological innovations. She co-authored the CONSORT extension for pilot trials and collaborates extensively on healthcare interventions. Notably, she holds £25 million in research grants and is an NIHR Senior Investigator, Fellow of the Royal Statistical Society, and Honorary Fellow of the Royal College of General Practitioners. Her work emphasizes ethical design, transparency in reporting, and improving trial recruitment strategies. Beyond academia, she is an Anglican Priest, balancing her academic role with pastoral duties. Research Focus: Professor Eldridge’s research addresses methodological challenges in clinical trials, particularly cluster randomized and pragmatic trials. She advocates for rigorous reporting standards and ethical practices, contributing to frameworks like the CONSORT extension. Her work often intersects with health equity, such as reducing disparities in antenatal care and improving mental health outcomes through self-management interventions. Awards & Roles: NIHR Senior Investigator Fellow of the Royal College of General Practitioners (Honorary) Member of the Society for Academic Primary Care Former Chair of the Royal Statistical Society’s Primary Health Care Study Group Grants & Collaborations: With £25M in grants, she leads projects on trial methodologies, including the PROMETHEUS programme evaluating recruitment strategies. She collaborates on studies like the CHESS trial for chronic headache management and the CHILL study on urban air quality impacts.

Rajnikant Mehtaمشاهده پروفایل

پژوهشگر

• Clinical Trials Design
• Epidemiology
• Pain Management
• +۷ مورد دیگر

Rajnikant Mehta is a Senior Clinical Trials Statistician at Queen Mary University of London, affiliated with the Wolfson Institute of Population Health and Barts Clinical Trials Unit. He holds a BSc (Hons) in Mathematics, Statistics, and Computing from the University of Greenwich, an MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, and a Postgraduate Certificate in Academic Practice from the University of Southampton. With over 25 years of expertise, he has contributed to medical statistics, clinical trial design, and epidemiology across institutions including MRC Clinical Research Centre, GlaxoSmithKline, and multiple UK universities. His research focuses on optimizing clinical trial methodologies (e.g., cluster RCTs, stepped-wedge designs) and improving patient outcomes in areas like pain management and surgical trials. He has supported NIHR grant applications and collaborated with multidisciplinary teams to design fundable clinical trials. His work emphasizes methodological rigor and translational research to address public health challenges. Rajnikant’s publications span surgical outcomes, pain management innovations, and systematic reviews in specialties like ophthalmology and neurology. He has contributed to guideline development and quality improvement initiatives in primary care, emphasizing patient safety and avoidable harm reduction. His career includes academic teaching roles and leadership in clinical trial units across the UK.

Michael Ookoمشاهده پروفایل

پژوهشگر

• Clinical Trial Methodology
• Infectious Disease Modelling
• Medical Statistics
• +۳ مورد دیگر

Mr. Michael Ooko is a PCTU/RSS Statistician at Queen Mary University of London's Wolfson Institute of Population Health. He holds a BSc in Applied Statistics from Maseno University (2007–2011) and an MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine (LSHTM) (2015–2016), funded by the Wellcome Trust. His career includes roles at the KEMRI Wellcome Trust Research Programme (2012–2016), Phastar Limited (2019–2020), and a Research Fellowship at LSHTM/The MRC Unit in The Gambia (2021–2024). His research focuses on clinical trial methodology, including cluster randomized trials, interrupted time series, and simulation studies, alongside infectious disease modeling with a malaria focus. He currently supports clinical trials at the PCTU and advises the NIHR Research Support Service Hub at Imperial College London & Partners. His research interests span statistical methods for trial design and analysis, with applications to global health challenges like malaria and vaccine efficacy. His work bridges methodological innovation and practical implementation in resource-limited settings.

Peter Hajekمشاهده پروفایل

استاد

• Tobacco dependence
• Weight management
• Health behaviours
• +۳ مورد دیگر

Professor Peter Hajek is a leading academic in clinical psychology and public health at Queen Mary University of London's Wolfson Institute of Population Health. He directs the Health and Lifestyle Research Unit, focusing on tobacco dependence, weight management, and health behavior modification. His work has globally influenced smoking cessation policies, including the UK’s Specialist Stop Smoking Services. Current research explores e-cigarette safety/efficacy, nicotine product substitution, and scalable weight management strategies. Key projects include multi-million pound studies funded by CRUK, NIHR, and international bodies. Notable studies examine e-cigarette impacts on homeless populations, pregnancy outcomes, and smoking cessation efficacy compared to varenicline. Hajek also leads community clinics providing stop-smoking and weight management services, integrating teaching on addiction and medical psychology across Queen Mary's medical curriculum. His research portfolio includes £2.2M NIHR grants for COPD vaping studies and £1.6M NIHR funds for homeless-centered cessation trials. Over 200 publications span Cochrane reviews, randomized controlled trials, and policy-informing analyses. Hajek collaborates internationally on editorial boards and expert groups, emphasizing evidence-based harm reduction strategies for nicotine use.

Clare Marie Robinsonمشاهده پروفایل

مدرس ارشد

• Medical Statistics
• Clinical Trials
• Epidemiology
• +۳ مورد دیگر

Dr Clare Marie Robinson is a Senior Lecturer in Medical Statistics at the Wolfson Institute of Population Health, Queen Mary University of London. She joined QMUL in 2009 after roles at the Medical Research Council and Institute of Psychiatry. Her academic career spans clinical trial statistics, statistical methodology for healthcare research, and leadership in pilot trials research. She previously worked in the pharmaceutical industry and took a career break to focus on family life before returning in 2020. Education: BSc Mathematics & Applied Statistics (First Class, University of Reading), MSc Statistics with Applications in Medicine (Distinction, University of Southampton), PhD in Primary Care & Public Health (Queen Mary University of London), and Postgraduate Certificate in Academic Practice (University of London). Research focuses on statistical methods for clinical trials, particularly cluster randomized trials, sample size calculations for ordinal outcomes, and methodological challenges in trial design. Her work bridges statistical rigor and real-world healthcare applications, including domestic violence intervention evaluations and public health policy impact assessments. Current roles include joint lead of the pilot trials research group at the Wolfson Institute and senior statistician in the Pragmatic Clinical Trials Unit. Supervision includes advising Saskia Eddy on external randomized controlled pilot trials. Her contributions emphasize improving trial design transparency and methodological quality in population health research.

• Dental Public Health
• Oral Cancer
• Dental Education
• +۴ مورد دیگر

Nilesh Shah, PhD, is an Assistant Professor in the Department of Dental Public Health at the University of Pittsburgh School of Dental Medicine. His education includes a B.S. from Case Western University (2001) and a PhD from the University of Pittsburgh (2012). His research focuses on implementation science, oral cancer recurrence mechanisms, dental education challenges, and evidence-based guideline adoption in clinical practice. He has conducted studies on factors influencing oral squamous cell carcinoma recurrence, dental sealant implementation in managed care systems, and dental student transitions into professional education. Key projects include a stepped-wedge trial evaluating deliberative engagement to improve guideline adherence and a longitudinal study on dental students' experiences transitioning from undergraduate to professional training. His work addresses disparities in healthcare delivery, academic stress management, and clinical guideline effectiveness. Collaborations with institutions like Kaiser Permanente Northwest Dental highlight his focus on real-world application of research findings. Publications span journals like PLoS ONE, Journal of the American Dental Association, and Implementation Science Communications. He advises on dental curriculum design, patient care protocols, and health policy. His lab focuses on translational research bridging academic findings to clinical practice improvements, with ongoing studies on opioid prescribing trends and preventive dental care strategies.

Matthew Jonesمشاهده پروفایل

پژوهشگر ارشد

• Mental Health
• Opioid Use Disorder
• Gambling Disorders
• +۴ مورد دیگر

Dr. Matthew Jones is an Honorary Research Fellow at Swansea University's Faculty of Medicine, Health and Life Science, specializing in mental health research with particular focus on gambling disorders and opioid use disorder (OUD). His current position involves working as a research officer on the SAGE study (Scoping the Accessibility of Safer Gambling Information in the United Kingdom Armed Forces: A Pilot Evaluation Study), funded by GREO with Professor Simon Dymond, Matt Fossey, and Justyn Larcombe. This research involves surveying and interviewing armed forces personnel, affected others, and healthcare professionals to capture data related to gambling and mental health, as well as evaluating screening tools for problem gamblers in the military. Dr. Jones' research interests primarily center around the intersection of mental health and substance use disorders, with significant work in opioid use disorder and gambling disorders. His work employs diverse methodologies including data linkage studies, qualitative analysis, and clinical trials. A substantial portion of his recent research examines the unique mental health challenges faced by military personnel, particularly regarding gambling behaviors and associated mental health conditions. His earlier work extensively investigated opioid overdose decedents in Wales using cross-sectional data linkage studies, examining socio-demographics and health service utilization patterns. Analysis of Dr. Jones' publication record reveals a clear trajectory focusing on public health interventions for substance use disorders. His research spans both clinical and population health approaches, with recent work emphasizing military populations while maintaining his expertise in opioid-related research. The publications demonstrate strong interdisciplinary collaboration across emergency medicine, psychiatry, and public health domains, with particular emphasis on harm reduction strategies and innovative screening tools. Dr. Jones has been actively involved in significant research grants, most notably the SAGE study examining gambling in UK Armed Forces. His career history shows progression from Research Assistant (2016-2017) to Research Officer (2017-2020) within Swansea University Medical School's Health Services Research department, indicating growing responsibility in research projects. While no specific scientific awards are listed in the available information, his consistent publication record in reputable journals demonstrates recognition within his research community. Dr. Jones' work demonstrates a commitment to translating research into practical interventions, particularly in the areas of opioid overdose prevention and gambling harm reduction. His current focus on military populations represents an important expansion of his research into specialized population groups with unique mental health challenges. The integration of both qualitative and quantitative approaches in his methodology portfolio highlights his comprehensive approach to understanding complex health behaviors and developing effective interventions.

Feifang Huمشاهده پروفایل

استاد

• Adaptive design of clinical trials
• Bioinformatics
• Biostatistics
• +۴ مورد دیگر

Feifang Hu is a Professor and Department Chair in the Department of Statistics at George Washington University. His expertise includes adaptive design of clinical trials, bioinformatics, biostatistics, bootstrap methods, statistical issues in personalized medicine, financial econometrics, and stochastic processes. He holds a PhD from the University of British Columbia (1994). His research focuses on developing and refining statistical methodologies for clinical trials, particularly in covariate-adaptive randomization and response-adaptive designs, with applications in precision medicine and network-based trials. Dr. Hu has published extensively in top journals such as the Journal of the American Statistical Association, Biometrics, and Annals of Statistics. His work emphasizes balancing covariates in experimental designs, improving statistical inference under adaptive frameworks, and addressing challenges in real-world clinical data. His contributions include theoretical advancements in urn models, sequential monitoring, and efficient randomized allocation strategies. Notably, Dr. Hu’s research trends highlight innovations in handling delayed responses, missing covariates, and network structures in trials. He has developed the 'carat' R package to facilitate covariate-adaptive randomization in clinical studies. His work bridges statistical theory and practical applications, influencing modern clinical trial design and personalized medicine.

Satish Iyengarمشاهده پروفایل

استاد

• Diffusion processes
• Point processes
• Multivariate mixture models
• +۴ مورد دیگر

Satish Iyengar is a Professor and Associate Chair in the Department of Statistics at the University of Pittsburgh, affiliated with the Dietrich School of Arts and Sciences. He also holds an affiliation with the Department of Psychiatry and serves on the FDA’s Psychopharmacologic Drugs Advisory Committee. He earned his PhD in Statistics from Stanford University (1982) and a BA in Mathematics from Harvard University (1978). His research focuses on diffusion processes, point processes, multivariate mixture models, and applications in psychiatry and neuroscience, including meta-analysis. Education: PhD in Statistics, Stanford University, 1982 BA in Mathematics, Harvard University, 1978 Research Interests: His work bridges computational neuroscience, statistical methodology, and clinical psychiatry. Key areas include modeling neural activity, analyzing psychiatric clinical trials (e.g., antidepressant efficacy and suicide risk), and developing statistical frameworks for complex biological data. He has contributed to methodological advancements in meta-analysis and diffusion models. Awards: He received the P.R. Krishnaiah Memorial Lectureship (2017) and the University of Pittsburgh Provost’s Graduate Mentoring Award (2018). Advising & Grants: Advisor to 28 PhD students and multiple postdoctoral researchers. His advisees hold prominent roles in academia, industry, and healthcare. He has collaborated on grants involving statistical applications in neuroscience and clinical research. Affiliations: Besides his primary role at Pitt’s Statistics Department, he contributes to FDA drug advisory processes and interdisciplinary collaborations in psychiatry and neuroscience.

Prun Bijralمشاهده پروفایل

استاد آموزشی

• Addiction Psychiatry
• Substance Use Disorders
• Methadone Treatment
• +۳ مورد دیگر

Dr. Prun Bijral is an Honorary Teaching Fellow at the University of St Andrews School of Medicine, specializing in addiction psychiatry and substance use disorders. His research focuses on interventions for opioid and methadone treatment adherence, contingency management strategies, and public health implications of illicit drug use. He holds a Bachelor of Medicine from the University of St Andrews (1996) and a combined Bachelor of Medicine and Surgery from the University of Manchester (1998). He serves as a National Clinical Advisor at the Chief Scientist Office and Executive Medical Director at Change Grow Live. His work includes landmark studies on fentanyl prevalence among opioid users, feasibility of mobile health interventions for methadone adherence, and cluster randomized trials evaluating contingency management for heroin abstinence. Collaborations involve institutions like the Royal College of Psychiatrists and the National Addiction Centre. Dr. Bijral’s expertise spans clinical trials, policy development, and translational research in addiction medicine, with a focus on evidence-based practices to improve treatment outcomes and reduce harm.